CNBX Pharmaceuticals Statistics
Total Valuation
CNBX has a market cap or net worth of 376,598. The enterprise value is 1.56 million.
| Market Cap | 376,598 |
| Enterprise Value | 1.56M |
Important Dates
The last earnings date was Monday, December 1, 2025.
| Earnings Date | Dec 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CNBX has 753.20 million shares outstanding. The number of shares has increased by 199.69% in one year.
| Current Share Class | 753.20M |
| Shares Outstanding | 753.20M |
| Shares Change (YoY) | +199.69% |
| Shares Change (QoQ) | +501.38% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 3.27% |
| Float | 752.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.96 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.76 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -681.68% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 10.88% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -313,976 |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.44% in the last 52 weeks. The beta is -0.35, so CNBX's price volatility has been lower than the market average.
| Beta (5Y) | -0.35 |
| 52-Week Price Change | -94.44% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 57.80 |
| Average Volume (20 Days) | 11,789,446 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -271,691 |
| Pretax Income | -313,976 |
| Net Income | -313,976 |
| EBITDA | -199,371 |
| EBIT | -271,691 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 15,111 in cash and 1.20 million in debt, giving a net cash position of -1.18 million or -0.00 per share.
| Cash & Cash Equivalents | 15,111 |
| Total Debt | 1.20M |
| Net Cash | -1.18M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -2.50M |
| Book Value Per Share | -0.00 |
| Working Capital | -2.50M |
Cash Flow
| Operating Cash Flow | -171,305 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -199.69% |
| Shareholder Yield | -199.69% |
| Earnings Yield | -83.37% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 12, 2022. It was a reverse split with a ratio of 0.0083333.
| Last Split Date | May 12, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0083333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |